share_log
Reuters ·  Apr 1 11:30
Organon Acquires Tofidence™ (Tocilizumab-Bavi), a Commercialized Biosimilar to Actemra® (Tocilizumab) Injection, for Intravenous Infusion in the U.S.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 256

Recommended

Write a comment